Skip to content
10-Q

Quarterly Report

DAY ONE BIOPHARMACEUTICALS, INC.

0000950170-25-103012

← back to feed
Filed
Aug 5, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Jul 31, 2025 102.43M sh
Shares Diluted Q2 2025 · Jun 30, 2025 103.07M sh
Shares Diluted Q2 2025 · Jun 30, 2025 102.89M sh
Shares Diluted Q2 2025 · Jun 30, 2024 87.12M sh
Shares Diluted Q2 2025 · Jun 30, 2024 86.86M sh
Capex Q2 2025 · Jun 30, 2025 $320K
Capex Q2 2025 · Jun 30, 2024 $26K
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$83.8M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$98.86M
Short Term Investments Q2 2025 · Jun 30, 2025 $417.48M
Short Term Investments Q2 2025 · Dec 31, 2024 $406.75M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $35.62M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $124.97M
Stockholders Equity Q2 2025 · Jun 30, 2025 $460.83M
Stockholders Equity Q2 2025 · Mar 31, 2025 $479.51M
Stockholders Equity Q2 2025 · Dec 31, 2024 $502.75M
Stockholders Equity Q2 2025 · Jun 30, 2024 $306.73M
Stockholders Equity Q2 2025 · Mar 31, 2024 $296.81M
Stockholders Equity Q2 2025 · Dec 31, 2023 $346.54M
Current Liabilities Q2 2025 · Jun 30, 2025 $51.22M
Current Liabilities Q2 2025 · Dec 31, 2024 $73.45M
Total Liabilities Q2 2025 · Jun 30, 2025 $58.2M
Total Liabilities Q2 2025 · Dec 31, 2024 $80.04M
Current Assets Q2 2025 · Jun 30, 2025 $494.43M
Current Assets Q2 2025 · Dec 31, 2024 $562.33M
Total Assets Q2 2025 · Jun 30, 2025 $519.04M
Total Assets Q2 2025 · Dec 31, 2024 $582.79M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.29
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.64
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.05
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.77
Eps Basic Q2 2025 · Jun 30, 2025 −$0.29
Eps Basic Q2 2025 · Jun 30, 2025 −$0.64
Eps Basic Q2 2025 · Jun 30, 2024 −$0.05
Eps Basic Q2 2025 · Jun 30, 2024 −$0.77
Sga Expense Q2 2025 · Jun 30, 2025 $28.97M
Sga Expense Q2 2025 · Jun 30, 2025 $58.29M
Sga Expense Q2 2025 · Jun 30, 2024 $30.19M
Sga Expense Q2 2025 · Jun 30, 2024 $56.74M
Rd Expense Q2 2025 · Jun 30, 2025 $36.15M
Rd Expense Q2 2025 · Jun 30, 2025 $75.77M
Rd Expense Q2 2025 · Jun 30, 2024 $92.11M
Rd Expense Q2 2025 · Jun 30, 2024 $132.32M
Net Income Q2 2025 · Jun 30, 2025 −$30.32M
Net Income Q2 2025 · Jun 30, 2025 −$66.32M
Net Income Q2 2025 · Mar 31, 2025 −$36M
Net Income Q2 2025 · Jun 30, 2024 −$4.41M
Net Income Q2 2025 · Jun 30, 2024 −$66.82M
Net Income Q2 2025 · Mar 31, 2024 −$62.41M
Operating Income Q2 2025 · Jun 30, 2025 −$34.97M
Operating Income Q2 2025 · Jun 30, 2025 −$76.04M
Operating Income Q2 2025 · Jun 30, 2024 −$114.81M
Operating Income Q2 2025 · Jun 30, 2024 −$181.57M
Revenue Q2 2025 · Jun 30, 2025 $33.91M
Revenue Q2 2025 · Jun 30, 2025 $64.67M
Revenue Q2 2025 · Jun 30, 2024 $8.19M
Revenue Q2 2025 · Jun 30, 2024 $8.19M